Chiamaka L. Okorie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Chiamaka L. Okorie has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Alicia T. Dagrosa
Department of Dermatology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA
3 shared publications Raven Bennett
Geisel School of Medicine at Dartmouth , Hanover, NH , USA
2 shared publications- Shaofeng Yan
Department of Pathology Dartmouth Hitchcock Medical Center Lebanon New Hampshire USA
2 shared publications - Vinod E. Nambudiri
Harvard Medical School, Boston, USA
2 shared publications - A. Aziz Ould Ismail
Department of Pathology and Laboratory Medicine, Dartmouth Hitchcock Medical Center, Lebanon, NH, USA
1 shared publication Andrew J. Scripture
Department of Dermatology Dartmouth Hitchcock Medical Center Lebanon New Hampshire USA
1 shared publication
Latest Publications
- 14 December 2024
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 317 (1) , 1-3
Integrating social prescribing in dermatology policy and clinical practice: enhancing care beyond medical interventions
- 14 December 2024
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 317 (1) , 1-3
Integrating social prescribing in dermatology policy and clinical practice: enhancing care beyond medical interventions
- 4 November 2023
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 49 (4) , 313-324
Vascular cutaneous manifestations of COVID-19 and RNA viral pathogens: a systematic review
Background: COVID-19, the widely recognized and highly contagious respiratory tract infection, has had a substantial impact on the field of dermatology since its emergence in 2019. SARS-CoV-2, the causative virus of COVID-19, is classified as an RNA virus. Various skin-related symptoms have been reported in patients with COVID-19, most notably the distinctive purple–red acral rash resembling chilblain lesions, commonly referred to as ‘COVID toe’; similarly, skin-related symptoms have been observed in connection with other RNA viruses. Objectives: To explore the relationship between RNA viruses and their associated vascular cutaneous manifestations vs. those observed in patients infected with SARS-CoV-2. Methods: A systematic literature review was conducted using PubMed and medical subject heading terms related to RNA viruses and related skin manifestations. Results: In total, 3994 patients diagnosed with COVID-19 presenting with skin rashes were included. Chilblain-like lesions were most frequently observed (30.2%), followed by erythematous maculopapular/morbilliform rashes (9.1%) and urticarial rashes (4.7%). Of 8362 patients diagnosed with RNA viruses, more than half of the skin findings reported were erythematous/maculopapular/morbilliform rashes (52.3%), followed by unspecified (11.3%) and purpuric rashes (10.6%). Conclusions: When comparing RNA viral infections with COVID-19 infection, we observed similarities in the reported skin manifestations and their presumed pathways, with many implicated in the proinflammatory response. Owing to the wide range of cutaneous symptoms associated with RNA viruses and our currently limited understanding of the underlying mechanisms, additional research is warranted to investigate the pathology behind viral-induced skin lesions.
- 4 November 2023
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 49 (4) , 313-324
Vascular cutaneous manifestations of COVID-19 and RNA viral pathogens: a systematic review
Background: COVID-19, the widely recognized and highly contagious respiratory tract infection, has had a substantial impact on the field of dermatology since its emergence in 2019. SARS-CoV-2, the causative virus of COVID-19, is classified as an RNA virus. Various skin-related symptoms have been reported in patients with COVID-19, most notably the distinctive purple–red acral rash resembling chilblain lesions, commonly referred to as ‘COVID toe’; similarly, skin-related symptoms have been observed in connection with other RNA viruses. Objectives: To explore the relationship between RNA viruses and their associated vascular cutaneous manifestations vs. those observed in patients infected with SARS-CoV-2. Methods: A systematic literature review was conducted using PubMed and medical subject heading terms related to RNA viruses and related skin manifestations. Results: In total, 3994 patients diagnosed with COVID-19 presenting with skin rashes were included. Chilblain-like lesions were most frequently observed (30.2%), followed by erythematous maculopapular/morbilliform rashes (9.1%) and urticarial rashes (4.7%). Of 8362 patients diagnosed with RNA viruses, more than half of the skin findings reported were erythematous/maculopapular/morbilliform rashes (52.3%), followed by unspecified (11.3%) and purpuric rashes (10.6%). Conclusions: When comparing RNA viral infections with COVID-19 infection, we observed similarities in the reported skin manifestations and their presumed pathways, with many implicated in the proinflammatory response. Owing to the wide range of cutaneous symptoms associated with RNA viruses and our currently limited understanding of the underlying mechanisms, additional research is warranted to investigate the pathology behind viral-induced skin lesions.
- 19 September 2023
- Published by Wiley in Experimental Dermatology
- Vol. 33 (1)
Cutaneous findings and treatments in deficiency of interleukin‐36 receptor antagonist ( DITRA ): A review of the literature
Deficiency of the interleukin‐36 receptor antagonist (DITRA) is a rare autoinflammatory disorder caused by mutations in the IL36RN gene. This mutation leads to a lack of functional interleukin‐36 receptor antagonists (IL‐36Ra), which results in an overactive immune system and chronic inflammation. Despite its rarity, numerous case series and individual reports in the literature emphasize the importance of recognizing and managing DITRA. Early identification of the cutaneous signs of DITRA is crucial for accurate diagnosis and timely administration of appropriate treatment. This review article provides a comprehensive overview of the current understanding of the cutaneous, non‐cutaneous and histopathological manifestations of DITRA, with a focus on reported treatments. The disease typically presents in early childhood, although the age of onset can vary. Patients with DITRA exhibit recurrent episodes of skin inflammation, often with a pustular or pustular psoriasis‐like appearance. Additionally, non‐cutaneous manifestations are common, with recurrent fevers and elevated acute‐phase reactants being the most prevalent. The exact prevalence of DITRA is unknown. Some cases of loss‐of‐function mutations in the IL36RN gene, considered a hallmark for diagnosis, have been identified in patients with familial generalized pustular psoriasis (GPP). Biological therapies with inhibition of IL‐12/23 and IL‐17 are promising treatment options; paediatric patients with DITRA have shown complete response with mild relapses. New and emerging biologic therapeutics targeting the IL‐36 pathway are also of interest in the management of this rare autoinflammatory disorder.
- 19 September 2023
- Published by Wiley in Experimental Dermatology
- Vol. 33 (1)
Cutaneous findings and treatments in deficiency of interleukin‐36 receptor antagonist ( DITRA ): A review of the literature
Deficiency of the interleukin‐36 receptor antagonist (DITRA) is a rare autoinflammatory disorder caused by mutations in the IL36RN gene. This mutation leads to a lack of functional interleukin‐36 receptor antagonists (IL‐36Ra), which results in an overactive immune system and chronic inflammation. Despite its rarity, numerous case series and individual reports in the literature emphasize the importance of recognizing and managing DITRA. Early identification of the cutaneous signs of DITRA is crucial for accurate diagnosis and timely administration of appropriate treatment. This review article provides a comprehensive overview of the current understanding of the cutaneous, non‐cutaneous and histopathological manifestations of DITRA, with a focus on reported treatments. The disease typically presents in early childhood, although the age of onset can vary. Patients with DITRA exhibit recurrent episodes of skin inflammation, often with a pustular or pustular psoriasis‐like appearance. Additionally, non‐cutaneous manifestations are common, with recurrent fevers and elevated acute‐phase reactants being the most prevalent. The exact prevalence of DITRA is unknown. Some cases of loss‐of‐function mutations in the IL36RN gene, considered a hallmark for diagnosis, have been identified in patients with familial generalized pustular psoriasis (GPP). Biological therapies with inhibition of IL‐12/23 and IL‐17 are promising treatment options; paediatric patients with DITRA have shown complete response with mild relapses. New and emerging biologic therapeutics targeting the IL‐36 pathway are also of interest in the management of this rare autoinflammatory disorder.
- Open Access
Post-COVID Kawasaki-like Multisystem Inflammatory Syndrome Complicated by Herpes Simplex Virus-1 in a Two-Year-Old Child
Multisystem inflammatory syndrome in children (MIS-C) is a rare, systemic inflammation following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We report a case of a 2-year-old male who presented with an exanthem and aberrant laboratory markers, mimicking Kawasaki disease but failing to meet the full diagnostic criteria. His course was further complicated by herpes Simplex Virus-1 (HSV-1) stomatitis.
Open AccessPost-COVID Kawasaki-like Multisystem Inflammatory Syndrome Complicated by Herpes Simplex Virus-1 in a Two-Year-Old Child
Multisystem inflammatory syndrome in children (MIS-C) is a rare, systemic inflammation following severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We report a case of a 2-year-old male who presented with an exanthem and aberrant laboratory markers, mimicking Kawasaki disease but failing to meet the full diagnostic criteria. His course was further complicated by herpes Simplex Virus-1 (HSV-1) stomatitis.
- 4 September 2023
- Published by Oxford University Press (OUP) in Academic Medicine
- Vol. 98 (12) , 1346-1347
Challenges Faced by International Medical Students in the United States
An abstract is unavailable. This article is available as a PDF only.
- 4 September 2023
- Published by Oxford University Press (OUP) in Academic Medicine
- Vol. 98 (12) , 1346-1347
Challenges Faced by International Medical Students in the United States
An abstract is unavailable. This article is available as a PDF only.
- 24 July 2023
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 315 (8) , 1-3
Trends in sex and ethnicity among U.S. dermatopathology and Mohs surgery trainees: 2011–2021
Dermatology has been cited as the second-least racially diverse medical specialty in the United States. In the last decade, the American Academy of Dermatology (AAD), the Skin of Color Society (SOCS), the Dermatology Section of the National Medical Association (NMA), and other stakeholders have made significant efforts to increase diversity in dermatology. This study aims to explore the potential impact of these efforts by analyzing sex and ethnic trends in ACGME-accredited dermatology fellowships; Mohs surgery, and dermatopathology, using data from 2011–2021. Our findings reveal that over the last decade, significant strides to increase sex diversity within dermatology have led to a growing number of female resident trainees (62%). This trend is also reflected in Mohs surgery (50%) and dermatopathology (52%) fellowships. In addition, the proportion of Underrepresented in medicine (URiM) fellowship trainees has also increased significantly over the last decade, with a now similar proportion of URiM trainees between dermatology residency, Mohs surgery, and dermatopathology.
- 24 July 2023
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 315 (8) , 1-3
Trends in sex and ethnicity among U.S. dermatopathology and Mohs surgery trainees: 2011–2021
Dermatology has been cited as the second-least racially diverse medical specialty in the United States. In the last decade, the American Academy of Dermatology (AAD), the Skin of Color Society (SOCS), the Dermatology Section of the National Medical Association (NMA), and other stakeholders have made significant efforts to increase diversity in dermatology. This study aims to explore the potential impact of these efforts by analyzing sex and ethnic trends in ACGME-accredited dermatology fellowships; Mohs surgery, and dermatopathology, using data from 2011–2021. Our findings reveal that over the last decade, significant strides to increase sex diversity within dermatology have led to a growing number of female resident trainees (62%). This trend is also reflected in Mohs surgery (50%) and dermatopathology (52%) fellowships. In addition, the proportion of Underrepresented in medicine (URiM) fellowship trainees has also increased significantly over the last decade, with a now similar proportion of URiM trainees between dermatology residency, Mohs surgery, and dermatopathology.
- 21 July 2023
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 48 (12) , 1370-1372
Answering the call to diversify the dermatology curriculum in undergraduate medical education
Limited exposure to dermatological diseases across a range of skin tones can lead to diagnostic inaccuracies and lower diagnostic self-confidence. This study demonstrates that a short-term dermatology course is feasible and beneficial for increasing diagnostic skills across a range of skin tones, especially when skin of colour education is intentional.
- 21 July 2023
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 48 (12) , 1370-1372
Answering the call to diversify the dermatology curriculum in undergraduate medical education
Limited exposure to dermatological diseases across a range of skin tones can lead to diagnostic inaccuracies and lower diagnostic self-confidence. This study demonstrates that a short-term dermatology course is feasible and beneficial for increasing diagnostic skills across a range of skin tones, especially when skin of colour education is intentional.
- Open Access
- 5 July 2023
- Published by Elsevier in JAAD Case Reports
- Vol. 39, 30-33
A case of topical 5-fluorouracil provoked psoriasis
- 5 July 2023
- Published by Elsevier in JAAD Case Reports
- Vol. 39, 30-33
Open AccessA case of topical 5-fluorouracil provoked psoriasis
- 7 May 2023
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 51 (1) , 15-19
Unusual presentations of chronic graft versus host disease
Skin is commonly affected by graft versus host disease (GVHD), a complication of bone marrow transplantation (BMT). One‐third of hematopoietic cell transplantation recipients develop acute eruption classically described as folliculocentric, maculopapular, or morbilliform, in contrast to the more common chronic presentations of sclerotic, poikilodermic, or lichenoid dermatitides. With the wider use of non‐myeloablative (reduced‐intensity) transplant therapy, various atypical presentations can occur, representing a diagnostic challenge. Herein, we report an unusual case of chronic GVHD manifested by two distinct clinical and histopathological features lacking the classical presentation. Five months after her BMT, the patient presented with a papulosquamous eruption on her neck, trunk, and arms showing a psoriasiform histopathological pattern of chronic GVHD. She also demonstrated multiple small flesh‐colored papules on her distal extremities showing a solitary syringotropic pattern of GVHD, demonstrated by interface dermatitis involving the superficial eccrine duct, as the only diagnostic histopathological feature of GVHD. This report, with review of literature, highlights the uncommon psoriasiform GVHD and the novel description of isolated syringotropic chronic GVHD.
- 7 May 2023
- Published by Wiley in Journal of Cutaneous Pathology
- Vol. 51 (1) , 15-19
Unusual presentations of chronic graft versus host disease
Skin is commonly affected by graft versus host disease (GVHD), a complication of bone marrow transplantation (BMT). One‐third of hematopoietic cell transplantation recipients develop acute eruption classically described as folliculocentric, maculopapular, or morbilliform, in contrast to the more common chronic presentations of sclerotic, poikilodermic, or lichenoid dermatitides. With the wider use of non‐myeloablative (reduced‐intensity) transplant therapy, various atypical presentations can occur, representing a diagnostic challenge. Herein, we report an unusual case of chronic GVHD manifested by two distinct clinical and histopathological features lacking the classical presentation. Five months after her BMT, the patient presented with a papulosquamous eruption on her neck, trunk, and arms showing a psoriasiform histopathological pattern of chronic GVHD. She also demonstrated multiple small flesh‐colored papules on her distal extremities showing a solitary syringotropic pattern of GVHD, demonstrated by interface dermatitis involving the superficial eccrine duct, as the only diagnostic histopathological feature of GVHD. This report, with review of literature, highlights the uncommon psoriasiform GVHD and the novel description of isolated syringotropic chronic GVHD.